Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-24-046767
Filing Date
2024-04-12
Accepted
2024-04-12 16:15:20
Documents
1
Group Members
COSTAS CONSTANTINIDESIAN CHAROUBNEXTECH VI ONCOLOGY SCSPROCCO SGOBBO

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2411733d1_sc13d.htm SC 13G 112149
  Complete submission text file 0001104659-24-046767.txt   113846
Mailing Address 9880 CAMPUS POINT DRIVE SUITE 120 SAN DIEGO CA 92121
Business Address 9880 CAMPUS POINT DRIVE SUITE 120 SAN DIEGO CA 92121 (858) 766-9912
Boundless Bio, Inc. (Subject) CIK: 0001782303 (see all company filings)

EIN.: 830751369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94492 | Film No.: 24841640
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 8 RUE LOU HEMMER SENNINGERBERG N4 L-1748
Business Address 8 RUE LOU HEMMER SENNINGERBERG N4 L-1748 41.443666611
Nextech VI GP S.A.R.L. (Filed by) CIK: 0001826420 (see all company filings)

EIN.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13G